SanegeneBio is a global, clinical-stage biotechnology company developing best-in-class RNAi (RNA interference) genetic medicines for obesity, cardiometabolic, and autoimmune diseases, powered by its proprietary LEAD™ delivery and chemistry platform, with R&D operations in Boston, Suzhou, and Shanghai.
About the role
We are seeking a hands-on Senior Accountant or Accounting Manager to join our Finance team as we continue to grow. This is a high-visibility, multi-disciplinary role for someone who wants ownership beyond a traditional accounting position. You will anchor our monthly close, support FP&A reporting for our R&D pipeline and help lead our transition to a new accounting/ERP system.
This role is ideal for a self-starter who thrives in a lean, collaborative environment and is comfortable taking ownership across multiple areas of Finance.
This is an onsite role based in our Woburn, MA office. We value in-person teamwork and collaboration and expect employees to work primarily from the office. At the same time, we understand that individual circumstances may occasionally require flexibility, and we are open to accommodating those needs when appropriate.
Compensation and level will be determined based on the candidate’s experience, qualifications, and overall fit for the role.
Key responsibilities
1.Month-end close — key owner
- Own the monthly and quarterly close end-to-end across 7 non-China legal entities.
- Prepare and/or review journal entries, account reconciliations, and consolidation eliminations, including intercompany transactions.
- Ensure project-code and department-code accuracy in the GL, partnering with R&D and departmental approvers; drive close-calendar adherence and process improvements.
- Prepare consolidated financial statements and supporting schedules for management and audit review.
2.Income tax provision & compliance
- Track ASC 740 income tax provision information and coordinate with external tax compliance team on PBC list. Assist with tracking current and deferred tax, valuation-allowance analysis, and effective-tax-rate reconciliation.
- Maintain NOL carryforward schedules, Section 382 limitation tracking, and other tax-attribute rollforwards.
- Coordinate with external tax advisors on transfer-pricing / cost-sharing documentation, R&D tax credit substantiation, and multi-jurisdictional compliance (U.S. federal/state, Cayman, Hong Kong, New Zealand, & Australia).
- Prepare tax account rollforwards and audit-ready workpapers.
3.FP&A support
- Assist with FP&A on budget-vs-actual reporting at the program / project-code level.
- Assist with quarterly reforecasts, cash-runway modeling, and ad-hoc reporting.
- Support R&D accrual management (CRO/CDMO) and spend-variance analysis by program; contribute to long-range planning and ad hoc analysis
- Serve as a key finance-team resource on the transition to a new ERP system.
- Map the existing chart of accounts, project codes, and department codes into the new system architecture; design and test close, reconciliation, and reporting workflows.
- Document new processes and controls; train finance and non-finance stakeholders; partner with IT and implementation consultants on data migration and integration.
Qualifications
- Bachelor’s degree in Accounting or Finance; CPA or actively pursuing CPA strongly preferred.
- 4–7 years of progressive accounting experience, public accounting (Big 4 / national firm) and/or biotech or life-sciences industry preferred.
- Prior ERP implementation / system-conversion experience strongly preferred (NetSuite, Sage Intacct, SAP, or similar).
- Strong Excel; exposure to planning tools (Adaptive, Anaplan) a plus; multi-entity, cross-border and public experience preferred.
- Strong organizational skills and comfort managing competing priorities across tax, FP&A, close, and systems; excellent communication with R&D program leads, auditors, and other service providers.
- Solid experience and strong sense of ownership on full ledger closing is required. IFRS / US GAAP public company financial reporting experience is preferred.